Strs Ohio X4 Pharmaceuticals, Inc Transaction History

Strs Ohio

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Jul 23, 2020	SELL	$7.98 - $10.44 $24,738 - $32,364	-3,100 Closed	0 $0
Q3 2019 Oct 21, 2019	BUY	$11.06 - $15.75 $13,272 - $18,900	1,200 Added 63.16%	3,100 $39,000
Q2 2019 Jul 25, 2019	BUY	$12.57 - $21.67 $21,167 - $36,492	1,684 Added 779.63%	1,900 $28,000
Q1 2019 Apr 19, 2019	BUY	$15.19 - $22.98 $3,281 - $4,963	216 New	216 $3,000

99.6M

421K

80.6K

Ticker XFOR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,646,096
Market Cap $32.3M
Description
X4 Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is mavorixafor, a small molecule inhibitor of the chemokine receptor C-X-C chemokine receptor type 4 (CXCR4), which is in Phase...

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

Stay updated on Strs Ohio with notifications on news.